Company: STAA
Filing Date: 2025-12-10
Form Type: DEFA14A
Source: 0001193125-25-314435
Chunk: 18

Company: STAAR SURGICAL CO
Filing Date: 2025-12-10
Form: DEFA14A
Chunk 18
---
 to the executive as before termination (or, in the case of Mr. Farrell, reimbursement of group health coverage premiums for 24 months), as described under “— Employment Agreement” and “— Change in Control 
 Agreements” above. Such amounts are “double-trigger” (i.e., they are contingent upon a qualifying termination of employment in connection with the closing of the Merger).                                           |

| (4) | Messrs. Frinzi and Williams are former STAAR executives who are no longer employees of STAAR. Mr. Frinzi                                                                                                                                       
 is a party to a consulting agreement with STAAR that expires on January 26, 2026, and the STAAR RSU Awards granted to Mr. Frinzi during his employment with STAAR continue to vest during the term of the consulting agreement. Messrs. Frinzi 
 and Williams will not receive compensatory payments or benefits in connection with the Merger, other than outstanding STAAR RSU Awards held by Mr. Frinzi that will vest at the Effective Time as set forth in the table above.                |

(8) Supplements to “Regulatory Approvals Required for the Merger” and “Risk Factors” The last sentence of the first paragraph of the section titled “Proposal 1: Adoption of the Merger Agreement—Regulatory Approvals Required for the Merger—Required Regulatory Approvals” on page 76 of the proxy statement, and the last sentence of the first paragraph of the section of the Summary titled “—Regulatory Approvals Required for the Merger” on page 5 of the proxy statement, are hereby amended and supplemented as follows: The parties made the filings required under the HSR Act on August 29, 2025, and the initial 30-day waiting period willexpire dat 11:59 p.m., Eastern Time, on September 29, 2025 , unless otherwise terminated or extended. The first sentence of the first full paragraph on page 24 of the proxy statement, under the risk factor titled “The consummation of the Merger is subject to certain closing conditions…” is hereby amended and supplemented as follows: In addition, the consummation of the Merger is subject to the expiration or termination of the applicable waiting period (and any extension thereof) under the HSR Act (which waiting period willexpire don September 29, 2025 at 11:59 p.m., Eastern Time , unless otherwise earlier terminated or extended), as well as of any agreement not